235 related articles for article (PubMed ID: 15901861)
1. Asthma as a risk factor for invasive pneumococcal disease.
Talbot TR; Hartert TV; Mitchel E; Halasa NB; Arbogast PG; Poehling KA; Schaffner W; Craig AS; Griffin MR
N Engl J Med; 2005 May; 352(20):2082-90. PubMed ID: 15901861
[TBL] [Abstract][Full Text] [Related]
2. Risk of invasive pneumococcal infections among working age adults with asthma.
Klemets P; Lyytikäinen O; Ruutu P; Ollgren J; Kaijalainen T; Leinonen M; Nuorti JP
Thorax; 2010 Aug; 65(8):698-702. PubMed ID: 20685743
[TBL] [Abstract][Full Text] [Related]
3. Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population.
Romney MG; Hull MW; Gustafson R; Sandhu J; Champagne S; Wong T; Nematallah A; Forsting S; Daly P
Clin Infect Dis; 2008 Sep; 47(6):768-74. PubMed ID: 18690803
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of invasive streptococcus pneumoniae infections in children in Spain, 1996-1998.
Díez-Domingo J; Pereiró I; Morant A; Gimeno C; Lerma M; Oyagüez I; González A;
J Infect; 2002 Oct; 45(3):139-43. PubMed ID: 12387768
[TBL] [Abstract][Full Text] [Related]
5. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
6. Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study.
Hjuler T; Wohlfahrt J; Simonsen J; Kaltoft MS; Koch A; Kamper-Jørgensen M; Biggar RJ; Melbye M
Clin Infect Dis; 2007 Apr; 44(8):1051-6. PubMed ID: 17366448
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation.
Poehling KA; Szilagyi PG; Edwards K; Mitchel E; Barth R; Hughes H; Lafleur B; Schaffer SJ; Schwartz B; Griffin MR
Pediatr Infect Dis J; 2003 May; 22(5):413-8. PubMed ID: 12792380
[TBL] [Abstract][Full Text] [Related]
8. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
[TBL] [Abstract][Full Text] [Related]
9. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.
Whitney CG; Farley MM; Hadler J; Harrison LH; Bennett NM; Lynfield R; Reingold A; Cieslak PR; Pilishvili T; Jackson D; Facklam RR; Jorgensen JH; Schuchat A;
N Engl J Med; 2003 May; 348(18):1737-46. PubMed ID: 12724479
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.
Hofmann J; Cetron MS; Farley MM; Baughman WS; Facklam RR; Elliott JA; Deaver KA; Breiman RF
N Engl J Med; 1995 Aug; 333(8):481-6. PubMed ID: 7623880
[TBL] [Abstract][Full Text] [Related]
11. Recurrent invasive pneumococcal disease: a population-based assessment.
King MD; Whitney CG; Parekh F; Farley MM;
Clin Infect Dis; 2003 Oct; 37(8):1029-36. PubMed ID: 14523766
[TBL] [Abstract][Full Text] [Related]
12. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
[TBL] [Abstract][Full Text] [Related]
13. Incidence of invasive pneumococcal disease in Scotland, 1988-99.
Kyaw MH; Clarke S; Jones IG; Campbell H
Epidemiol Infect; 2002 Apr; 128(2):139-47. PubMed ID: 12002530
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of pediatric pneumococcal serotypes in elderly adults.
Feikin DR; Klugman KP; Facklam RR; Zell ER; Schuchat A; Whitney CG;
Clin Infect Dis; 2005 Aug; 41(4):481-7. PubMed ID: 16028155
[TBL] [Abstract][Full Text] [Related]
15. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
Shapiro ED; Berg AT; Austrian R; Schroeder D; Parcells V; Margolis A; Adair RK; Clemens JD
N Engl J Med; 1991 Nov; 325(21):1453-60. PubMed ID: 1944423
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for invasive pneumococcal disease among Navajo adults.
Watt JP; O'Brien KL; Benin AL; McCoy SI; Donaldson CM; Reid R; Schuchat A; Zell ER; Hochman M; Santosham M; Whitney CG
Am J Epidemiol; 2007 Nov; 166(9):1080-7. PubMed ID: 17693393
[TBL] [Abstract][Full Text] [Related]
17. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
[TBL] [Abstract][Full Text] [Related]
18. Risk factor analysis for pneumococcal meningitis in adults with invasive pneumococcal infection.
Burckhardt I; Burckhardt F; VAN DER Linden M; Heeg C; Reinert RR
Epidemiol Infect; 2010 Sep; 138(9):1353-8. PubMed ID: 20092671
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for invasive disease among children in Spain.
Pereiró I; Díez-Domingo J; Segarra L; Ballester A; Albert A; Morant A
J Infect; 2004 May; 48(4):320-9. PubMed ID: 15066333
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.
Dworkin MS; Ward JW; Hanson DL; Jones JL; Kaplan JE;
Clin Infect Dis; 2001 Mar; 32(5):794-800. PubMed ID: 11229848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
